연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Molecular and Medical Pharmacology
This submission is to adjust the dimension of the profile photo.
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 07, 2017 | Pubmed ID: 27879367
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.
Endocrine-related cancer 01, 2019 | Pubmed ID: 30400004
David Geffen School of Medicine, University of California, Los Angeles
University of California Los Angeles
Moe Ishihara*,1,
Junhui Hu*,1,
Xiaoyu Zhang2,
YongHyeon Choi3,
Anthony Wong4,
Celine Cano-Ruiz5,
Rongwei Zhao6,
Ping Tan7,
Jonathan L. Tso1,
Lily Wu1,8
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles,
2Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles,
3Department of Bioengineering, Hanyang University,
4Department of Ecology and Evolutionary Biology, University of California, Los Angeles,
5Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles,
6School of Life Sciences, Beijing Normal University,
7Department of Urology, West China Hospital, Sichuan University,
8Department of Urology, David Geffen School of Medicine, University of California, Los Angeles
Allison C. Sharrow1,
Moe Ishihara1,
Junhui Hu1,
Il Hyun Kim1,
Lily Wu1
1Molecular and Medical Pharmacology, University of California Los Angeles
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유